英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
muchedumbre查看　muchedumbre　在百度字典中的解释百度英翻中〔查看〕
muchedumbre查看　muchedumbre　在Google字典中的解释Google英翻中〔查看〕
muchedumbre查看　muchedumbre　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • List of CDK 4 6 inhibitors - Drugs. com
    CDK4 6 inhibitors are a class of drugs that target particular enzymes, called CDK4 and CDK6 CDK stands for cyclin-dependent kinase, and it is an enzyme that is important for cell division CDK4 6 inhibitors interrupt signals that stimulate the proliferation of malignant (cancerous) cells
  • Popular Cdk4 6 Inhibitors List, Drug Prices and Medication . . . - GoodRx
    Compare the cost of prescription and generic Cdk4 6 Inhibitors medications See information about popular Cdk4 6 Inhibitors, including the conditions they treat and alternatives available with or without insurance
  • Are the Three Approved CDK4 6 Inhibitors Truly Different?
    Cyclin-dependent kinase 4 and 6 (CDK4 6) inhibitors are a staple of care for patients with estrogen receptor-positive, HER2-negative (ER+ HER2-) breast cancer, but are they all the same or different?
  • CDK4 6 Inhibitors - Susan G. Komen®
    Abemaciclib (Verzenio) and ribociclib (Kisqali) are CDK4 6 inhibitor drugs They are given in combination with hormone therapy to treat some hormone receptor-positive, HER2-negative breast cancers
  • Updated Review Article: Cyclin-Dependent Kinase 4 6 Inhibitor Impact . . .
    Although the use of CDK4 6 inhibitors has improved PFS in patients with HR+ HER2− breast cancer, studies have shown that resistance pathways can cause cells to be insensitive to CDK4 6 inhibitors, leading to continued cell proliferation
  • What Are CDK4 6 Inhibitors? - Breastcancer. org
    CDK4 6 inhibitors are a class of medicines used to treat certain types of hormone receptor-positive, HER2-negative breast cancer These medicines interrupt the process through which breast cancer cells divide and multiply
  • FDA-Approved CDK4 6 Inhibitors for Early and Metastatic Breast Cancer
    Panelists discuss how FDA-approved CDK4 6 inhibitors are used in early breast cancer (abemaciclib and ribociclib with different trial designs and dosing regimens) and metastatic breast cancer (palbociclib, ribociclib, and abemaciclib showing approximately 2-year progression-free survival advantages in various combination therapies)
  • A Pharmacist’s Perspective on CDK4 6 Inhibitors
    The question of whether there is a preferred CDK4 6 inhibitor for select subsets of patients remains to be answered Future studies will better define the unique role and best overall value of palbociclib, ribociclib, and abemaciclib
  • A Review of CDK4 6 Inhibitors - U. S. Pharmacist
    Three CDK4 6 inhibitors (palbociclib, ribociclib, and abemaciclib) have been approved for patients with hormone receptor–positive, human epidermal growth factor receptor 2–negative advanced breast cancer
  • What are the brand names of CDK4 6 (Cyclin-Dependent Kinase 4 6 . . .
    The FDA-approved CDK4 6 inhibitors for breast cancer treatment include Ibrance (palbociclib), Kisqali (ribociclib), and Verzenio (abemaciclib) 1 These medications are primarily used in hormone receptor-positive, HER2-negative advanced or metastatic breast cancer





中文字典-英文字典  2005-2009